Cite
Visceral adipose tissue-directed human kallistatin gene therapy improves adipose tissue remodeling and metabolic health in obese mice.
MLA
Wu, Ya, et al. “Visceral Adipose Tissue-Directed Human Kallistatin Gene Therapy Improves Adipose Tissue Remodeling and Metabolic Health in Obese Mice.” Cellular Signalling, vol. 106, June 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.cellsig.2023.110637.
APA
Wu, Y., Jiang, Y., Guo, J., Yang, Z., Carvalho, A., Qian, L., Ji, J., Ji, Z., Ma, G., & Yao, Y. (2023). Visceral adipose tissue-directed human kallistatin gene therapy improves adipose tissue remodeling and metabolic health in obese mice. Cellular Signalling, 106, N.PAG. https://doi.org/10.1016/j.cellsig.2023.110637
Chicago
Wu, Ya, Yu Jiang, Jia-qi Guo, Zi-wei Yang, Abdlay Carvalho, Ling-lin Qian, Jing-jing Ji, Zhen-jun Ji, Gen-shan Ma, and Yu-yu Yao. 2023. “Visceral Adipose Tissue-Directed Human Kallistatin Gene Therapy Improves Adipose Tissue Remodeling and Metabolic Health in Obese Mice.” Cellular Signalling 106 (June): N.PAG. doi:10.1016/j.cellsig.2023.110637.